• Logo
  • SBMUJournals

In silico Analysis of Immunologic Regions of Surface Antigens (Sags) of Toxoplasma gondii

Abbas Alibakhshi, Mojgan Bandehpour, Tina Nafarieh, Shivasadat Gheflat, Bahram Kazemi
485

Views

PDF

Abstract

Background: Surface antigens (SAGs) of Toxoplasma gondii are known candidates for diagnostic tests and vaccines. The present study argues about the main necessary properties for determination and prediction of T-cell agretopes and B-cell epitopes of surface antigens of Toxoplasma gondii.

Materials and Methods: Primary, secondary and tertiary structures of the proteins were analyzed by different methods. The three-dimensional structures were determined by use of ab initio method for prediction of discontinues epitopes. The agretopes and epitopes were predicted via several various web servers with different methods employed.

Results: The results of in silico analyses showed that the regions 129-GAPAGRNNDGSSAPT-143 for protein p22, 234-SENPWQGNASSD-245 for protein p30 and 348-PGTEGESQAGT-358 for protein p43, have the highest immunogenic potential.

Conclusion: We reached to three antigenic epitopes for cloning and protein expression. In following the purified polypeptide will be applied for diagnosis of Toxoplasma gondii.


Keywords

Epitope, Agretope, SAG, Toxoplasma gondii, In silico

References

Innes EA. A brief history and overview of Toxoplasma gondii. Zoonoses Public Health. 2010;57(1):1-7.

Dubey JP. Chapter 1 - The History and Life Cycle of Toxoplasma gondii. In: Weiss LM, Kim K, editors. Toxoplasma Gondii (Second Edition). Boston: Academic Press; 2014. p. 1-17.

Sensini A. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect. 2006;12(6):504-312.

Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;12;363(9425):1965-1976.

Wang Y, Yin H. Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit Vectors. 2014;7:180.

Khanaliha K, Motazedian MH, Kazemi B, Shahriari B, Bandehpour M, Sharifniya Z. Evaluation of recombinant SAG1, SAG2, and SAG3 antigens for serodiagnosis of toxoplasmosis. Korean J Parasitol. 2014;52(2):137-142.

Kulkarni R, Sapkal G, Mahishi L, Shil P, Gore MM. Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus. Virus Res. 2012;166(1-2):77-86.

Karpenko LI, Bazhan SI, Antonets DV, Belyakov IM. Novel approaches in polyepitope T-cell vaccine development against HIV-1. Expert Rev Vaccines. 2014;13(1):155-173.

Barlow DJ, Edwards MS, Thornton JM. Continuous and discontinuous protein antigenic determinants. Nature. 1986;21-27;322(6081):747-8.

Van Regenmortel MH. Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J Mol Recognit. 2006;19(3):183-187.

Wang HW, Lin YC, Pai TW, Chang HT. Prediction of B-cell linear epitopes with a combination of support vector machine classification and amino acid propensity identification. J Biomed Biotechnol. 2011;2011:432830.

Benjamin DC. B-cell epitopes: fact and fiction. Adv Exp Med Biol. 1995;386:95-108.

Greenbaum JA, Andersen PH, Blythe M, Bui HH, Cachau RE, Crowe J, et al. Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J Mol Recognit. 2007;20(2):75-82.

Current Topics In Microbiology and Immunology. Toxoplasma gondii: Springer; 1996.

Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research. 1997;25(24):4876-82.

Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. Protein Identification and Analysis Tools on the ExPASy Server. In: Walker JM, editor. The Proteomics Protocols Handbook: Humana Press Inc; 2005.

Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305(3):567-780.

Dinkel H, Chica C, Via A, Gould CM, Jensen LJ, Gibson TJ, et al. Phospho.ELM: a database of phosphorylation sites--update 2011. Nucleic Acids Research. 2011;39(Database issue):D261-7.

Dor O, Zhou Y. Real-SPINE: an integrated system of neural networks for real-value prediction of protein structural properties. Proteins. 2007;68(1):76-81.

Cole C, Barber JD, Barton GJ. The Jpred 3 secondary structure prediction server. Nucleic Acids Research. 20081;36(Web Server issue):W197-201.

Ed D, J G, J-F G, B R. GOR secondary structure prediction method version IV. Methods in Enzymology. 1996;266:450-3.

Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Research. 2004;32(Web Server issue):W526-31.

Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2014;12(1):7-8.

Kunz AP, Allison JR, Geerke DP, Horta BA, Hunenberger PH, Riniker S, et al. New functionalities in the GROMOS biomolecular simulation software. J Comput Chem. 2012;33(3):340-53.

Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. Journal Of Applied Crystallography. 1993;26(2):283-91.

Bhattacharya A, Tejero R, Montelione GT. Evaluating protein structures determined by structural genomics consortia. Proteins. 2007;66(4):778-95.

Vita R, Overton JA, Greenbaum JA, Ponomarenko J, Clark JD, Cantrell JR, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Research. 2014.

Guan P, Hattotuwagama CK, Doytchinova IA, Flower DR. MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl Bioinformatics. 2006;5(1):55-61.

Schuler MM, Nastke MD, Stevanovikc S. SYFPEITHI: database for searching and T-cell epitope prediction. Methods in molecular biology. 2007;409:75-93.

Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics. 2001;17(12):1236-7.

Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, Dadmanesh M, Roayaei Ardakany A, et al. GB Virus C/Hepatitis G Virus Envelope Glycoprotein E2: Computational Molecular Features and Immunoinformatics Study. Hepat Mon. 2013;13(12):e15342.

Pelte C, Cherepnev G, Wang Y, Schoenemann C, Volk HD, Kern F. Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201. J Immunol. 2004;172(11):6783-9.

Saha S, Raghava GP. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65(1):40-8.

S S, G.P.S R. BcePred:Prediction of Continuous B-Cell Epitopes in Antigenic Sequences Using Physico-chemical Properties. LNCS. 2004;3239:197-204.

Larsen JE, Lund O, Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Res. 2006;2:2.

Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol. 1978;47:45-148.

Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 1985;55(3):836-9.

PA K, GE S. Prediction of Chain Flexibility in Proteins - A tool for the Selection of Peptide Antigens. Naturwissenschafren. 1985;72:212-3.

Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276(1-2):172-4.

Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry. 1986;25(19):5425-32.

Kringelum JV, Lundegaard C, Lund O, Nielsen M. Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Comput Biol. 2012;8(12):e1002829.

Ponomarenko J, Bui HH, Li W, Fusseder N, Bourne PE, Sette A, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. 2008;9:514.

Qi T, Qiu T, Zhang Q, Tang K, Fan Y, Qiu J, et al. SEPPA 2.0--more refined server to predict spatial epitope considering species of immune host and subcellular localization of protein antigen. Nucleic Acids Research. 201;42(Web Server issue):W59-63.

Goede A, Jaeger IS, Preissner R. SUPERFICIAL--surface mapping of proteins via structure-based peptide library design. BMC Bioinformatics. 2005;6:223.

Tomavo S, Schwarz RT, Dubremetz JF. Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens. Mol Cell Biol. 1989;9(10):4576-80.

Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157(1):105-32.

Ikai A. Thermostability and aliphatic index of globular proteins. J Biochem. 1980;88(6):1858-95.

Gavrilov BK, Rogers K, Fernandez-Sainz IJ, Holinka LG, Borca MV, Risatti GR. Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins. Virology. 2011;420(2):135-45.

Cheng S, Edwards SA, Jiang Y, Grater F. Glycosylation enhances peptide hydrophobic collapse by impairing solvation. Chemphyschem. 2010;11(11):2367-74.

Ubersax JA, Ferrell JE, Jr. Mechanisms of specificity in protein phosphorylation. Nat Rev Mol Cell Biol. 2007;8(7):530-41.

Draper JM, Xia Z, Smith CD. Cellular palmitoylation and trafficking of lipidated peptides. J Lipid Res. 2007;48(8):1873-84.

Letscher-Bru V, Pfaff AW, Abou-Bacar A, Filisetti D, Antoni E, Villard O, et al. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun. 2003;71(11):6615-9.

Yano A, Miwa Y, Kanazawa Y, Ito K, Makino M, Imai S, et al. A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines. Vaccine. 2013;31(11):1510-5.

Yano A, Onozuka A, Asahi-Ozaki Y, Imai S, Hanada N, Miwa Y, et al. An ingenious design for peptide vaccines. Vaccine. 2005;23(17–18):2322-6.




DOI: https://doi.org/10.22037/nbm.v5i3.14167